Belief Biomed (beijing) Co., Ltd

This early-stage study tests a new gene therapy called BBM-D101 in 9 boys aged 4 to 8 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help restore a missing muscle protein. Participants receive one infusion and are monitored for side effects and changes…

This early-stage study tests a new gene therapy called BBM-A101 for people with moderate knee osteoarthritis. The goal is to see if it is safe and can help reduce pain or improve joint function. About 81 adults with knee arthritis will receive the treatment and be monitored for s…